Lenz Therapeutics Inc (LENZ)

$33.40 +0.35 (1.06%)
Market Cap 928.26M
Revenue (ttm) 0.00
Net Income (ttm) -49.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 160,400
Avg Vol 275,250
Day's Range N/A - N/A
Shares Out 28.15M
Stochastic %K 29%
Beta 0.42
Analysts Strong Sell
Price Target $44.71

Company Profile

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, Cal...

Industry: Biotechnology
Sector: Healthcare
Phone: (858) 925-7000
Address:
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, United States
AngryElf
AngryElf Jul. 23 at 12:51 AM
@bmkb_24 Great to see you on here!!!!!!! I was just thinking about you and some of the VBIV crowd!!!!I'm into $LENZ currently, they are expecting FDA approval on 8/8 for eyedrops that can be used to prevent nearsightedness on a daily basis. I would love to know your thoughts on them! Really good to see your name on here again!!
0 · Reply
AngryElf
AngryElf Jul. 22 at 12:38 AM
$LENZ William Blair analysts probably get all their information from Paddy444.
1 · Reply
GoImugene
GoImugene Jul. 21 at 11:57 AM
$LENZ William Blair analysts estimate peak sales potential of $1 billion in the 2030s
1 · Reply
GoImugene
GoImugene Jul. 21 at 11:51 AM
$LENZ Company has the funds already to make it to the finish line and beyond. I expect a strong launch out of the gate in terms of sales. High current ratio bodes well.
0 · Reply
AngryElf
AngryElf Jul. 17 at 6:36 PM
$LENZ This is the hard hitting analysis and advice that I've come to love and expect from Paddy444! It is what truly separates him and makes him such a major improvement over Paddy443.
1 · Reply
Paddy444
Paddy444 Jul. 17 at 4:03 PM
$LENZ Even with a beaut wagon like Lenz, wheels can fall of still. Never go all in, never go balls deep unless you do the side to side. Diversify unless married. See ya, I'm pulling off the socks and heading back for a float Good luck they say, fk that, luck is when preparation meets opportunity Most of the time someone says good luck, its bullshit sarcasm thats so damn shallow Lets get shitcanned
0 · Reply
AngryElf
AngryElf Jul. 16 at 12:05 AM
$BE $BMNR $CIFR $COGT $LENZ Is anyone else picking up on the significance of the 444,444 shares? If not, perhaps ask Paddy444....
2 · Reply
G101SPM
G101SPM Jul. 15 at 2:28 PM
#INSIDERS $BMNR Director bought 444,444 shares at $4.50 worth approximately $2 mln. $BXSY 10% owner bought 12,982 shares of beneficial interest at $13.58 - $13.59 worth approximately $176K. $COGT 10% owner Fairmount Funds Management bought 2,777,777 shares at $9.00 worth approximately $25 mln. $BE 10% owner SK ecoplant sold 10,000,000 shares at $27.60 worth ~$276000K. $CIFR 10% owner Bitfury sold 1,032,990 shares at $6.00 - $6.5081 worth more than $6.4 mln. $LENZ 10% owner Versant Venture Capital sold 191,376 shares at $34.00 worth approximately $6.5 mln.
1 · Reply
Mandi63
Mandi63 Jul. 15 at 1:44 PM
$AEON $CDLI $INKT $LENZ $AEON Next month $2-5 $EOLS EUROPEAN PARTNERS ALREADY SELLING THIS DRUG
0 · Reply
Kmiles98
Kmiles98 Jul. 13 at 6:40 AM
$LENZ What @Paddy444 Said!!!! 💯 lol!!
1 · Reply
Latest News on LENZ
LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

Jul 7, 2025, 8:00 AM EDT - 17 days ago

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

LENZ Therapeutics: Presbyopia Eyedrops Look Promising

Jul 1, 2025, 4:23 PM EDT - 23 days ago

LENZ Therapeutics: Presbyopia Eyedrops Look Promising

LENZ Therapeutics to Present at Upcoming Investor Conferences

May 27, 2025, 8:00 AM EDT - 2 months ago

LENZ Therapeutics to Present at Upcoming Investor Conferences

LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript

May 9, 2025, 10:33 AM EDT - 2 months ago

LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia

May 9, 2025, 9:03 AM EDT - 2 months ago

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia

LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 7, 2025, 4:05 PM EDT - 2 months ago

LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference

May 6, 2025, 4:30 PM EDT - 2 months ago

LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference

LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025

Apr 30, 2025, 4:30 PM EDT - 3 months ago

LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025

LENZ Therapeutics: Freedom From Reading Glasses

Apr 7, 2025, 8:00 AM EDT - 3 months ago

LENZ Therapeutics: Freedom From Reading Glasses

LENZ Therapeutics Stock Is Attractive Before PDUFA

Mar 27, 2025, 5:33 PM EDT - 4 months ago

LENZ Therapeutics Stock Is Attractive Before PDUFA

LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 8:09 PM EDT - 4 months ago

LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 19, 2025, 4:05 PM EDT - 4 months ago

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025

Mar 11, 2025, 8:00 AM EDT - 4 months ago

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025

LENZ Therapeutics to Host Commercial Day on April 15, 2025

Mar 3, 2025, 8:00 AM EST - 5 months ago

LENZ Therapeutics to Host Commercial Day on April 15, 2025

LENZ Therapeutics to Participate in Upcoming Investor Conferences

Feb 24, 2025, 8:00 AM EST - 5 months ago

LENZ Therapeutics to Participate in Upcoming Investor Conferences

LENZ Therapeutics, Inc. (LENZ) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 11:43 AM EST - 9 months ago

LENZ Therapeutics, Inc. (LENZ) Q3 2024 Earnings Call Transcript

LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships

Oct 28, 2024, 1:51 PM EDT - 9 months ago

LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships

CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100

Oct 27, 2024, 9:00 PM EDT - 9 months ago

CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100

LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia

Oct 21, 2024, 8:00 AM EDT - 9 months ago

LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 10 months ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

ABOS

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

Aug 30, 2024, 8:00 AM EDT - 11 months ago

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 7:43 PM EDT - 1 year ago

LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings Call Transcript

LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Aug 14, 2024, 4:05 PM EDT - 1 year ago

LENZ Therapeutics Reports Second Quarter 2024 Financial Results

LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

Aug 12, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

Aug 7, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024

Jun 10, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024

LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference

May 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference

LENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call Transcript

May 11, 2024, 7:26 AM EDT - 1 year ago

LENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call Transcript

LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 8, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

May 1, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

Lenz Therapeutics' eye disease drugs meet main goal of late-stage study

Apr 3, 2024, 7:49 AM EDT - 1 year ago

Lenz Therapeutics' eye disease drugs meet main goal of late-stage study

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

Apr 3, 2024, 7:00 AM EDT - 1 year ago

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials

Apr 2, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials

LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

Mar 21, 2024, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

AngryElf
AngryElf Jul. 23 at 12:51 AM
@bmkb_24 Great to see you on here!!!!!!! I was just thinking about you and some of the VBIV crowd!!!!I'm into $LENZ currently, they are expecting FDA approval on 8/8 for eyedrops that can be used to prevent nearsightedness on a daily basis. I would love to know your thoughts on them! Really good to see your name on here again!!
0 · Reply
AngryElf
AngryElf Jul. 22 at 12:38 AM
$LENZ William Blair analysts probably get all their information from Paddy444.
1 · Reply
GoImugene
GoImugene Jul. 21 at 11:57 AM
$LENZ William Blair analysts estimate peak sales potential of $1 billion in the 2030s
1 · Reply
GoImugene
GoImugene Jul. 21 at 11:51 AM
$LENZ Company has the funds already to make it to the finish line and beyond. I expect a strong launch out of the gate in terms of sales. High current ratio bodes well.
0 · Reply
AngryElf
AngryElf Jul. 17 at 6:36 PM
$LENZ This is the hard hitting analysis and advice that I've come to love and expect from Paddy444! It is what truly separates him and makes him such a major improvement over Paddy443.
1 · Reply
Paddy444
Paddy444 Jul. 17 at 4:03 PM
$LENZ Even with a beaut wagon like Lenz, wheels can fall of still. Never go all in, never go balls deep unless you do the side to side. Diversify unless married. See ya, I'm pulling off the socks and heading back for a float Good luck they say, fk that, luck is when preparation meets opportunity Most of the time someone says good luck, its bullshit sarcasm thats so damn shallow Lets get shitcanned
0 · Reply
AngryElf
AngryElf Jul. 16 at 12:05 AM
$BE $BMNR $CIFR $COGT $LENZ Is anyone else picking up on the significance of the 444,444 shares? If not, perhaps ask Paddy444....
2 · Reply
G101SPM
G101SPM Jul. 15 at 2:28 PM
#INSIDERS $BMNR Director bought 444,444 shares at $4.50 worth approximately $2 mln. $BXSY 10% owner bought 12,982 shares of beneficial interest at $13.58 - $13.59 worth approximately $176K. $COGT 10% owner Fairmount Funds Management bought 2,777,777 shares at $9.00 worth approximately $25 mln. $BE 10% owner SK ecoplant sold 10,000,000 shares at $27.60 worth ~$276000K. $CIFR 10% owner Bitfury sold 1,032,990 shares at $6.00 - $6.5081 worth more than $6.4 mln. $LENZ 10% owner Versant Venture Capital sold 191,376 shares at $34.00 worth approximately $6.5 mln.
1 · Reply
Mandi63
Mandi63 Jul. 15 at 1:44 PM
$AEON $CDLI $INKT $LENZ $AEON Next month $2-5 $EOLS EUROPEAN PARTNERS ALREADY SELLING THIS DRUG
0 · Reply
Kmiles98
Kmiles98 Jul. 13 at 6:40 AM
$LENZ What @Paddy444 Said!!!! 💯 lol!!
1 · Reply
Paddy444
Paddy444 Jul. 11 at 9:17 PM
$LENZ I just keep doing it over and over again, its ok. Not big deal 444 Might want to take a peekaboo Silky and fluffy socks, how is that possible. And without hurting or using others. Its ok, details always matter
1 · Reply
Paddy444
Paddy444 Jul. 11 at 9:15 PM
$LENZ
0 · Reply
LowCountry15
LowCountry15 Jul. 11 at 6:53 PM
$LENZ where does this go on approval?
4 · Reply
Quantumup
Quantumup Jul. 11 at 6:21 PM
William Blair, on 7/7, reiterated $LENZ at an Outperform rating and said, "We see a potential blockbuster opportunity for LNZ100," after Lenz announced an exclusive license and commercialization agreement with Laboratoires Théa for LNZ100 in Canada." $ABBV William Blair additionally said:
0 · Reply
AngryElf
AngryElf Jul. 11 at 2:42 AM
$LENZ Thank you for sharing. Naturally, I will wait for Paddy444's in depth analysis to fully ascertain the implications of this .
2 · Reply
Kmiles98
Kmiles98 Jul. 10 at 3:08 PM
$LENZ great article today. https://www.ophthalmologytimes.com/view/lenz-therapeutics-and-laboratoires-th-a-partner-to-commercialize-lnz100-for-presbyopia-in-canada
0 · Reply
Doozio
Doozio Jul. 9 at 11:17 PM
👀 thru da $LENZ of 🐒🍌🧠⏰♾️
0 · Reply
Kmiles98
Kmiles98 Jul. 7 at 12:50 PM
$LENZ I think what @Paddy444 is saying is positive??lol
1 · Reply
Paddy444
Paddy444 Jul. 7 at 12:31 PM
$LENZ Take care all.. Just Paddy, just results over and over without hurting others Done around this site, so stay cool, going to get back to more living and less thoughts that come with this site Later 444
1 · Reply
DonCorleone77
DonCorleone77 Jul. 7 at 12:13 PM
$LENZ Lenz Therapeutics, Laboratoires Thea enter license, commercialization agreement LENZ Therapeutics announced an exclusive license and commercialization agreement for Thea to register and commercialize LNZ100 for the treatment of presbyopia in Canada. LENZ Therapeutics is a pre-commercial stage biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in people with presbyopia, which has a US FDA PDUFA date of August 8, 2025. Thea is an independent pharmaceutical company specialized in the research, development and commercialization of eye-care products. Under the terms of the licensing and commercialization agreement, LENZ will be eligible to receive over $70M in upfront, regulatory and commercial milestone payments, as well as tiered, double-digit royalties on net sales. Thea will have exclusive development, manufacturing, registration and commercialization rights for LNZ100 for the treatment of presbyopia in Canada.
2 · Reply
Kmiles98
Kmiles98 Jul. 7 at 4:51 AM
$LENZ The countdown begins!!!
0 · Reply
HypnoTrader
HypnoTrader Jul. 5 at 8:53 PM
$LENZ insiders are selling because this stock is guaranteed to go way up. They are good people and want small investors to be able to get money as well. Insiders are already rich and now want to give back to the investor community.
2 · Reply